Simplex Trading’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-17,221
| Closed | -$281K | – | 9849 |
|
|
2026
Q1 | $281K | Buy |
17,221
+14,945
| +657% | +$283K | ﹤0.01% | 3895 |
|
|
2025
Q4 | $47.9K | Buy |
+2,276
| New | +$61.7K | ﹤0.01% | 5693 |
|
|
2024
Q1 | – | Sell |
-3,800
| Closed | -$368K | – | 9379 |
|
|
2023
Q4 | $368K | Buy |
+3,800
| New | +$739K | ﹤0.01% | 4013 |
|
|
2023
Q2 | – | Sell |
-728
| Closed | -$149K | – | 9489 |
|
|
2023
Q1 | $149K | Buy |
+728
| New | +$124K | ﹤0.01% | 4679 |
|
|
2022
Q4 | – | Sell |
-5,209
| Closed | -$1.25M | – | 9834 |
|
|
2022
Q3 | $1.25M | Buy |
5,209
+4,447
| +584% | +$1.03M | ﹤0.01% | 2398 |
|
|
2022
Q2 | $296K | Sell |
762
-817
| -52% | -$410K | ﹤0.01% | 4117 |
|
|
2022
Q1 | $553K | Buy |
1,579
+954
| +153% | +$374K | ﹤0.01% | 3722 |
|
|
2021
Q4 | $160K | Buy |
625
+493
| +373% | +$113K | ﹤0.01% | 5499 |
|
|
2021
Q3 | $23K | Sell |
132
-70
| -35% | -$14.9K | ﹤0.01% | 8321 |
|
|
2021
Q2 | $38K | Sell |
202
-941
| -82% | -$211K | ﹤0.01% | 7969 |
|
|
2021
Q1 | $248K | Buy |
+1,143
| New | +$222K | ﹤0.01% | 4416 |
|
|
2020
Q4 | – | Sell |
-781
| Closed | -$465K | – | 8733 |
|
|
2020
Q3 | $465K | Buy |
781
+101
| +15% | +$65.2K | ﹤0.01% | 3092 |
|
|
2020
Q2 | $471K | Buy |
+680
| New | +$854K | ﹤0.01% | 2986 |
|
|
2020
Q1 | – | Sell |
-171
| Closed | -$422K | – | 7938 |
|
|
2019
Q4 | $422K | Buy |
171
+77
| +82% | +$273K | ﹤0.01% | 2918 |
|
|
2019
Q3 | $478K | Sell |
94
-84
| -47% | -$346K | ﹤0.01% | 2671 |
|
|
2019
Q2 | $641K | Buy |
178
+76
| +75% | +$320K | ﹤0.01% | 2345 |
|
|
2019
Q1 | $374K | Sell |
102
-28
| -22% | -$136K | ﹤0.01% | 2965 |
|
|
2018
Q4 | $1.11M | Buy |
130
+124
| +2,067% | +$910K | ﹤0.01% | 1550 |
|
|
2018
Q3 | $30K | Buy |
+6
| New | +$29K | ﹤0.01% | 5642 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$8K | – | 6335 |
|
|
2017
Q3 | $8K | Sell |
1
-5
| -83% | -$60.3K | ﹤0.01% | 3995 |
|
|
2017
Q2 | $87K | Buy |
6
+4
| +200% | +$76.9K | ﹤0.01% | 1874 |
|
|
2017
Q1 | $34K | Sell |
2
-4
| -67% | -$98.9K | ﹤0.01% | 2733 |
|
|
2016
Q4 | $225K | Sell |
6
-4
| -40% | -$154K | 0.01% | 969 |
|
|
2016
Q3 | $343K | Buy |
10
+6
| +150% | +$281K | 0.02% | 697 |
|
|
2016
Q2 | $300K | Buy |
4
+3
| +300% | +$242K | 0.02% | 769 |
|
|
2016
Q1 | $93K | Buy |
+1
| New | +$128K | 0.01% | 1423 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3399 |
|
Other funds holding LABD
HF
IC
JF
XT
TSS
Simplex Trading's LABD Position: Q2 2026 in Review
Simplex Trading sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026, closing a stake of 17,221 shares — an estimated $281K sold.
Simplex Trading first reported a position in LABD in Q1 2016 and held it in 26 quarters. The position peaked at $1.25M in Q3 2022. 21 funds tracked by Wall St. Rank hold LABD as of Q2 2026.
- Simplex Trading reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 17,221 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2026, an estimated $281K.
- Simplex Trading first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2016 and held it in 26 quarters.
- Simplex Trading's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.25M in Q3 2022.
- 21 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.